1. Home
  2. PRTC vs CVGW Comparison

PRTC vs CVGW Comparison

Compare PRTC & CVGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • CVGW
  • Stock Information
  • Founded
  • PRTC 2015
  • CVGW 1924
  • Country
  • PRTC United States
  • CVGW United States
  • Employees
  • PRTC N/A
  • CVGW N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • CVGW Specialty Foods
  • Sector
  • PRTC Health Care
  • CVGW Consumer Discretionary
  • Exchange
  • PRTC Nasdaq
  • CVGW Nasdaq
  • Market Cap
  • PRTC 509.0M
  • CVGW 517.5M
  • IPO Year
  • PRTC N/A
  • CVGW N/A
  • Fundamental
  • Price
  • PRTC $22.55
  • CVGW $27.17
  • Analyst Decision
  • PRTC Buy
  • CVGW Hold
  • Analyst Count
  • PRTC 1
  • CVGW 1
  • Target Price
  • PRTC $45.00
  • CVGW $32.00
  • AVG Volume (30 Days)
  • PRTC 4.5K
  • CVGW 115.5K
  • Earning Date
  • PRTC 08-28-2024
  • CVGW 01-14-2025
  • Dividend Yield
  • PRTC N/A
  • CVGW 1.84%
  • EPS Growth
  • PRTC N/A
  • CVGW N/A
  • EPS
  • PRTC N/A
  • CVGW N/A
  • Revenue
  • PRTC $468,000.00
  • CVGW $1,011,635,000.00
  • Revenue This Year
  • PRTC N/A
  • CVGW N/A
  • Revenue Next Year
  • PRTC $139.60
  • CVGW $3.27
  • P/E Ratio
  • PRTC N/A
  • CVGW N/A
  • Revenue Growth
  • PRTC N/A
  • CVGW 45.46
  • 52 Week Low
  • PRTC $17.08
  • CVGW $20.30
  • 52 Week High
  • PRTC $34.00
  • CVGW $31.26
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 59.26
  • CVGW 45.37
  • Support Level
  • PRTC $20.61
  • CVGW $26.61
  • Resistance Level
  • PRTC $22.83
  • CVGW $30.02
  • Average True Range (ATR)
  • PRTC 0.69
  • CVGW 0.78
  • MACD
  • PRTC 0.04
  • CVGW -0.10
  • Stochastic Oscillator
  • PRTC 68.44
  • CVGW 16.42

About PRTC PureTech Health plc

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

About CVGW Calavo Growers Inc.

Calavo Growers Inc is in the avocado industry and an expanding provider of value-added fresh food. The company distributes its products both domestically and internationally and reports its operations in two different business segments: Grown and Prepared. The Grown segment consists of fresh avocados, tomatoes, and papayas. The Prepared segment comprises all other products including fresh-cut fruits and vegetables, ready-to-eat sandwiches, wraps, salads and snacks, guacamole, and salsa sold at retail and food service as well as avocado pulp sold to food service.

Share on Social Networks: